Padma P. Tadi Uppala Discussed Research Analyzing Natural Therapies to Combat COVID-19

Video

A presentation from the AACR Virtual Meeting: COVID-19 and Cancer detailed a literature review of natural therapeutics and remedies to combat the SARS CoV-2 virus.

CancerNetwork® spoke with Padma P. Tadi Uppala, professor and director of the Public Health Program at Andrews University, regarding her research from the AACR Virtual Meeting: COVID-19 and Cancer.

Uppala, along with her research partners, performed an exploratory analysis about evidence-based natural therapies and foods that naturally enhance the immune system with the goal of combatting the SARS CoV-2 virus.

“It’s a systematic literature review of evidence-based natural therapies to prevent and treat COVID-19,” explained Uppala. “It’s based on the fact that SARS CoV-2 dysregulates the innate immune system, so I wanted to look at literature to find if natural therapies can strengthen the innate immune system.”

The results, which relied heavily on data about the 1918 Spanish Flu as well as existing literature, found that foods such as blueberries, garlic, and probiotics were shown to improve natural killer activity, while Vitamin C, Vitamin D, Zinc, and selenium were integral in immunity.

This segment comes from the CancerNetwork® portion of the MJH Life Sciences™ Medical World News®, airing daily on all MJH Life Sciences™ channels.

Recent Videos
Optimal cancer survivorship care may entail collaboration between a treating oncologist and a cancer survivorship expert.
Survivors of cancer may experience an increased risk of having organ, cardiac, or lung disease following prior anti-cancer therapy.
Performing ablation and injecting tumor sites with immunotherapy may be “synergistic”, according to Jason R. Williams, MD, DABR.
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
The Together for Supportive Cancer Care coalition may advance the national conversation in ensuring comprehensive care for all patients with cancer.
Health care organizations have come together to form the Together for Supportive Cancer Care coalition to address gaps in supportive cancer care services.
Further optimizing a PROTAC that targets MDM2 may lead to human clinical trials among patients with cancer harboring p53 mutations.
Related Content